Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
<i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer
PaperCitations, authors & open-access status
<i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 138 citations, 2018 year and bronze oa status.
138
Citations
2018
Year
bronze
OA Status